Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vonoprazan Study In Patients With Erosive Esophagitis to Evaluate Long-term Safety: A Study to Evaluate the Safety of Long-term Administration of Vonoprazan in Maintenance Treatment in Patients With Erosive Esophagitis (EE)

NCT02679508 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02679508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vonoprazan Study In Patients With Erosive Esophagitis to Evaluate Long-term Safety: A Study to Evaluate the Safety of Long-term Administration of Vonoprazan in Maintenance Treatment in Patients With Erosive Esophagitis (EE)
Lead sponsor
Takeda
Phase
Phase 4
Overall status
Completed
Start date
March 20, 2016
Completion date
March 5, 2022
Enrollment
208 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

erosive esophagitis